investorscraft@gmail.com

Intrinsic ValueSichuan Development Lomon Co., Ltd. (002312.SZ)

Previous Close$12.33
Intrinsic Value
Upside potential
Previous Close
$12.33

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Sichuan Development Lomon operates as a diversified industrial company with dual business segments in China's basic materials sector. The company maintains a significant presence in the phosphorus chemical industry, producing essential agricultural and industrial products including industrial grade monoammonium phosphate, feed-grade calcium hydrogen phosphate, and fertilizer-grade monoammonium phosphate. These products serve critical downstream markets in agriculture, animal nutrition, and industrial applications, positioning the company within China's strategic food security and industrial supply chains. Simultaneously, the company provides specialized financial outsourcing services to the banking sector, offering business process optimization, platform centralized management, and big data analytics solutions. This dual-operational model creates a unique market position that combines traditional chemical manufacturing with modern financial technology services. Within the competitive Chinese chemical landscape, the company leverages its established production capabilities and regional advantages in Sichuan province, while its financial services division capitalizes on the growing demand for operational efficiency in China's banking industry. The integration of these seemingly disparate businesses reflects a strategic approach to diversification across different economic cycles and market conditions.

Revenue Profitability And Efficiency

The company generated CNY 8.18 billion in revenue with net income of CNY 532.9 million, reflecting a net margin of approximately 6.5%. Operating cash flow stood at CNY 732.3 million, demonstrating reasonable conversion of earnings to cash. Capital expenditures of CNY 969.8 million indicate significant ongoing investment in productive capacity, which may support future growth but currently represents a substantial cash outflow relative to operating cash generation.

Earnings Power And Capital Efficiency

Diluted earnings per share of CNY 0.28 reflects the company's current earnings capacity relative to its 1.89 billion shares outstanding. The substantial capital expenditure program suggests management is prioritizing capacity expansion or operational improvements, though this investment has temporarily reduced free cash flow generation. The company's ability to maintain profitability while undertaking significant capital investments indicates disciplined capital allocation.

Balance Sheet And Financial Health

The company maintains a solid liquidity position with CNY 2.95 billion in cash and equivalents against total debt of CNY 4.08 billion. This debt level represents a moderate leverage position, providing financial flexibility while maintaining conservative risk management. The balance sheet structure supports both ongoing operations and strategic investments without excessive financial risk.

Growth Trends And Dividend Policy

The company demonstrates a commitment to shareholder returns with a dividend per share of CNY 0.141, representing a payout ratio of approximately 50% based on current EPS. This balanced approach returns capital to shareholders while retaining earnings for reinvestment. The significant capital expenditure program suggests management is positioning for future growth, particularly in its core chemical operations.

Valuation And Market Expectations

With a market capitalization of CNY 21.82 billion, the company trades at a price-to-earnings ratio of approximately 41 times trailing earnings, suggesting market expectations for future growth. The exceptionally low beta of 0.026 indicates minimal correlation with broader market movements, potentially reflecting the company's unique business mix and specialized market positioning.

Strategic Advantages And Outlook

The company's strategic advantage lies in its dual-business model that spans traditional chemicals and modern financial services, providing diversification benefits. Its position in phosphorus chemicals benefits from China's agricultural needs, while financial outsourcing services capitalize on banking sector efficiency demands. The outlook depends on successful integration of capital investments and maintaining competitiveness in both operating segments amid evolving market conditions.

Sources

Company filingsMarket data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount